BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38191171)

  • 21. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
    Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.
    Liu H; Moore CL
    Trends Biochem Sci; 2021 Sep; 46(9):772-784. PubMed ID: 33941430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
    Huang S; Wu Z; Cheng Y; Wei W; Hao L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):743-752. PubMed ID: 31089713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent molecular insights into canonical pre-mRNA 3'-end processing.
    Sun Y; Hamilton K; Tong L
    Transcription; 2020 Apr; 11(2):83-96. PubMed ID: 32522085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
    Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
    PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCC3 is a novel target for the treatment of pancreatic cancer.
    Adamska A; Ferro R; Lattanzio R; Capone E; Domenichini A; Damiani V; Chiorino G; Akkaya BG; Linton KJ; De Laurenzi V; Sala G; Falasca M
    Adv Biol Regul; 2019 Aug; 73():100634. PubMed ID: 31053501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
    Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
    Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
    Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells.
    Tong Y; Guo D; Yan D; Ma C; Shao F; Wang Y; Luo S; Lin L; Tao J; Jiang Y; Lu Z; Xing D
    Cancer Lett; 2020 Jan; 469():1-10. PubMed ID: 31610265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated pre-mRNA 3' end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation.
    Cui Y; Wang L; Ding Q; Shin J; Cassel J; Liu Q; Salvino JM; Tian B
    Nat Commun; 2023 Aug; 14(1):4480. PubMed ID: 37528120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.
    Li S; Hong H; Lv H; Wu G; Wang Z
    Med Sci Monit; 2016 May; 22():1593-600. PubMed ID: 27170223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
    Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
    J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
    Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
    Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dinaciclib exerts a tumor-suppressing effect via β-catenin/YAP axis in pancreatic ductal adenocarcinoma.
    Li Y; Zheng Z; Xiao L; Chen Y; Liu X; Long D; Chai L; Li Y; Tan C
    Anticancer Drugs; 2024 Feb; 35(2):140-154. PubMed ID: 37694833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma.
    Bai Z; Du Y; Cong L; Cheng Y
    Gene; 2020 Oct; 758():144960. PubMed ID: 32687947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.
    Duan J; Li X; Huang S; Zeng Y; He Y; Liu H; Lin D; Lu D; Zheng M
    Mol Med Rep; 2018 Mar; 17(3):4187-4194. PubMed ID: 29344673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.